Loading clinical trials...
Loading clinical trials...
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Methodology Development Environmental Clinical Trial With Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects With Seasonal Allergic Conjunctivitis
Conditions
Interventions
Reproxalap Ophthalmic Solution (0.25%)
Reproxalap Ophthalmic Solution (0.5%)
+1 more
Locations
1
United States
Slade & Baker Vision
Houston, Texas, United States
Start Date
September 8, 2018
Primary Completion Date
November 19, 2019
Completion Date
November 19, 2019
Last Updated
April 8, 2025
NCT06686472
NCT05839938
NCT05186025
NCT01471184
NCT06602726
NCT05191186
Lead Sponsor
Aldeyra Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions